Multifaceted modes of action of the anticancer probiotic Enterococcus hirae

Goubet, AG; Wheeler, R; Fluckiger, A; Qu, B; Lemaitre, F; Iribarren, K; Mondragon, L; Alou, MT; Pizzato, E; Durand, S; Derosa, L; Aprahamian, F; Bossut, N; Moya-Nilges, M; Derrien, D; Chen, G; Leduc, M; Joseph, A; Pons, N; Le Chatelier, E; Segata, N; Yonekura, S; Iebba, V; Kepp, O; Raoult, D; Andre, F; Kroemer, G; Boneca, IG; Zitvogel, L; Daillere, R

Zitvogel, L; Daillere, R (corresponding author), Gustave Roussy Canc Campus GRCC, Villejuif, France.; Zitvogel, L (corresponding author), INSERM, U1015, Equipe Labellisee Ligue Natl Canc, Villejuif, France.; Zitvogel, L (corresponding author), Univ Paris Saclay, Fac Med, Le Kremlin Bicetre, France.; Daillere, R (corresponding author), Gustave Roussy Canc Ctr, EverImmune, Villejuif, France.; Zitvogel, L (corresponding author), Ctr Clin Invest BIOTHERIS, Villejuif, France.

CELL DEATH AND DIFFERENTIATION, 2021; 28 (7): 2276

Abstract

A deviated repertoire of the gut microbiome predicts resistance to cancer immunotherapy. Enterococcus hirae compensated cancer-associated dysbiosis in......

Full Text Link